©The Author(s) 2003.
World J Gastroenterol. Oct 15, 2003; 9(10): 2154-2159
Published online Oct 15, 2003. doi: 10.3748/wjg.v9.i10.2154
Published online Oct 15, 2003. doi: 10.3748/wjg.v9.i10.2154
Table 2 Intensity of Ets1 staining in tumor cell and distribu-tion of patients
| Compartment | No. | Weak (+) | Moderate (++) | Intense (≥ +++) | P value |
| Tumor cells | 40 | 6 (15%) | 24 (60%) | 10 (25%) | |
| T classification | |||||
| T1, 2 | 15 | 2 (13.3%) | 12 (80%) | 1 (6.7%) | 0.087 |
| T3, 4 | 25 | 4 (16%) | 12 (48%) | 9 (36%) | |
| LN metastasis | |||||
| Negative | 14 | 3 (21.4%) | 9 (64.3%) | 2 (14.3%) | 0.438 |
| Positive | 26 | 3 (11.5%) | 15 (57.7%) | 8 (30.8%) | |
| Distant metastasis | |||||
| Negative | 39 | 6 (15.4%) | 24 (61.5%) | 9 (23.1%) | 0.214 |
| Positive | 1 | 0 (0%) | 0 (0%) | 1 (100%) | |
| Clinical stage | |||||
| Stage I, II | 18 | 3 (16.7%) | 13 (72.2%) | 2 (11.1%) | 0.183 |
| Stage III, IV | 22 | 3 (13.6%) | 11 (50%) | 8 (36.4%) | |
- Citation: Yu Y, Zhang YC, Zhang WZ, Shen LS, Hertzog P, Wilson TJ, Xu DK. Ets1 as a marker of malignant potential in gastric carcinoma. World J Gastroenterol 2003; 9(10): 2154-2159
- URL: https://www.wjgnet.com/1007-9327/full/v9/i10/2154.htm
- DOI: https://dx.doi.org/10.3748/wjg.v9.i10.2154